WMT 10-Q Quarterly Report Oct. 31, 2024 | Alphaminr

WMT 10-Q Quarter ended Oct. 31, 2024

WALMART INC.
10-Ks and 10-Qs
10-Q
Quarter ended Oct. 31, 2024
10-Q
Quarter ended July 31, 2024
10-Q
Quarter ended April 30, 2024
10-K
Fiscal year ended Jan. 31, 2024
10-Q
Quarter ended Oct. 31, 2023
10-Q
Quarter ended July 31, 2023
10-Q
Quarter ended April 30, 2023
10-K
Fiscal year ended Jan. 31, 2023
10-Q
Quarter ended Oct. 31, 2022
10-Q
Quarter ended July 31, 2022
10-Q
Quarter ended April 30, 2022
10-K
Fiscal year ended Jan. 31, 2022
10-Q
Quarter ended Oct. 31, 2021
10-Q
Quarter ended July 31, 2021
10-Q
Quarter ended April 30, 2021
10-K
Fiscal year ended Jan. 31, 2021
10-Q
Quarter ended Oct. 31, 2020
10-Q
Quarter ended July 31, 2020
10-Q
Quarter ended April 30, 2020
10-K
Fiscal year ended Jan. 31, 2020
10-Q
Quarter ended Oct. 31, 2019
10-Q
Quarter ended July 31, 2019
10-Q
Quarter ended April 30, 2019
10-K
Fiscal year ended Jan. 31, 2019
10-Q
Quarter ended Oct. 31, 2018
10-Q
Quarter ended July 31, 2018
10-Q
Quarter ended April 30, 2018
10-K
Fiscal year ended Jan. 31, 2018
10-Q
Quarter ended Oct. 31, 2017
10-Q
Quarter ended July 31, 2017
10-Q
Quarter ended April 30, 2017
10-K
Fiscal year ended Jan. 31, 2017
10-Q
Quarter ended Oct. 31, 2016
10-Q
Quarter ended July 31, 2016
10-Q
Quarter ended April 30, 2016
10-K
Fiscal year ended Jan. 31, 2016
10-Q
Quarter ended Oct. 31, 2015
10-Q
Quarter ended July 31, 2015
10-Q
Quarter ended April 30, 2015
10-K
Fiscal year ended Jan. 31, 2015
10-Q
Quarter ended Oct. 31, 2014
10-Q
Quarter ended July 31, 2014
10-Q
Quarter ended April 30, 2014
10-K
Fiscal year ended Jan. 31, 2014
10-Q
Quarter ended Oct. 31, 2013
10-Q
Quarter ended July 31, 2013
10-Q
Quarter ended April 30, 2013
10-K
Fiscal year ended Jan. 31, 2013
10-Q
Quarter ended Oct. 31, 2012
10-Q
Quarter ended July 31, 2012
10-Q
Quarter ended April 30, 2012
10-K
Fiscal year ended Jan. 31, 2012
10-Q
Quarter ended Oct. 31, 2011
10-Q
Quarter ended July 31, 2011
10-Q
Quarter ended April 30, 2011
10-K
Fiscal year ended Jan. 31, 2011
10-Q
Quarter ended Oct. 31, 2010
10-Q
Quarter ended July 31, 2010
10-Q
Quarter ended April 30, 2010
10-K
Fiscal year ended Jan. 31, 2010
PROXIES
DEF 14A
Filed on April 25, 2024
DEF 14A
Filed on April 20, 2023
DEF 14A
Filed on April 21, 2022
DEF 14A
Filed on April 22, 2021
DEF 14A
Filed on April 23, 2020
DEF 14A
Filed on April 23, 2019
DEF 14A
Filed on April 20, 2018
DEF 14A
Filed on April 20, 2017
DEF 14A
Filed on April 20, 2016
DEF 14A
Filed on April 22, 2015
DEF 14A
Filed on April 23, 2014
DEF 14A
Filed on April 22, 2013
DEF 14A
Filed on April 16, 2012
DEF 14A
Filed on April 18, 2011
DEF 14A
Filed on April 19, 2010
TABLE OF CONTENTS
Part I. Financial InformationItem 1. Financial StatementsNote 1. Summary Of Significant Accounting PoliciesNote 2. Net Income Per Common ShareNote 3. Accumulated Other Comprehensive LossNote 4. Short-term Borrowings and Long-term DebtNote 5. Fair Value MeasurementsNote 6. ContingenciesNote 7. Segments and Disaggregated RevenueItem 2. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 5. Other InformationItem 6. Exhibits

Exhibits

Exhibit 3.1(a) Restated Certificate of Incorporation of the Company dated February 1, 2018 is incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed by the Company on February 1, 2018 Exhibit 3.1(b) Certificate of Amendment to the Restated Certificate of Incorporation of the Company, effective February 23, 2024 is incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed by the Company on February 23, 2024 Exhibit 3.2 Amended and Restated Bylaws of the Company dated November 10, 2022 are incorporated herein by reference to Exhibit 3.1 to the Report on Form 8-K filed by the Company on November 16, 2022 Exhibit 31.1* Chief Executive Officer Section 302 Certification Exhibit 31.2* Chief Financial Officer Section 302 Certification Exhibit 32.1** Chief Executive Officer Section 906 Certification Exhibit 32.2** Chief Financial Officer Section 906 Certification Exhibit 99.1* Opioids-Related Litigation Case Citations and Currently Scheduled Trial Dates